MYM Nutraceuticals Inc, (CSE: MYM) (OTCBB: MYMMF), a Canada-based company focused on the global growth of Cannabis and CBD-rich hemp, has named its current executives, Mark Forster and Paul Cheetham, as CFO and COO respectively of MYM International Brands Inc, it is reported today.
Both executives have transferred from MYM Nutraceuticals to the International Brands team to launch global expansion efforts of CBD-rich consumer products in a wide variety of categories, including food and beverage, pharmaceuticals, cosmetics, and health and wellness.
The company has also requested one of its present independent directors, Andrew Kent, to offer assistance by serving on the board of International Brands as an independent director, and accordingly he will step down as an independent director of the company while in that new capacity.
GelMEDIX completes USD13m seed financing, announces first partnership
AmacaThera named Life Sciences Ontario Emerging Company of the Year
GenSight Biologics reports first patient treated in GS010 REVISE study
Biophytis secures Asian partnership and investment to advance Phase 3 sarcopenia programme
MemorialCare hospitals recognised in 2026 Women's Choice Awards
Champions Oncology expands bioanalytical services with new technology and leadership
PhaseV receives three industry honours for AI in clinical development
Galapagos plans to wind down cell therapy business following strategic review
Sebela's MIUDELLA Hormone-Free Copper IUS recognised in TIME's best inventions of 2025
Revelation Pharma acquires Acacia Apothecary & Wellness
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers